Matthew W. Wilson
Department of Ophthalmology
University of Tennessee Health Science Center
Memphis
Tennessee 38163
USA
Name/email consistency: high
- Low-dose cyclophosphamide and interferon alfa 2a for the treatment of capillary hemangioma of the orbit. Wilson, M.W., Hoehn, M.E., Haik, B.G., Rieman, M., Reiss, U. Ophthalmology (2007)
- Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect? Wilson, M.W., Haik, B.G., Billups, C.A., Rodriguez-Galindo, C. Ophthalmology (2007)
- Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation. Wilson, M.W., Fraga, C.H., Fuller, C.E., Rodriguez-Galindo, C., Mancini, J., Hagedorn, N., Leggas, M.L., Stewart, C.F. Invest. Ophthalmol. Vis. Sci. (2006)
- Socioeconomic impact of modern multidisciplinary management of retinoblastoma. Wilson, M.W., Haik, B.G., Rodriguez-Galindo, C. Pediatrics (2006)
- Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Wilson, M.W., Haik, B.G., Liu, T., Merchant, T.E., Rodriguez-Galindo, C. Am. J. Ophthalmol. (2005)
- Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Wilson, M.W., Shergy, W.J., Haik, B.G. Ophthal. Plast. Reconstr. Surg (2004)
